Table 3 Comparison of pathological findings of CT-scan and MRI of patients
From: Comparative study of CT-scan modality with MRI modality findings in patients suspected of COVID-19
Pathologic findings | CT-scan | MRI | P value | ||||||
|---|---|---|---|---|---|---|---|---|---|
Has | Does not have | Has | Does not have | ||||||
Number | Percent | Number | Percent | Number | Percent | Number | Percent | ||
Consolidation | 32 | 60.4 | 21 | 39.6 | 32 | 60.4 | 21 | 39.6 | 1 |
Fibrosis | 2 | 3.8 | 51 | 96.2 | 2 | 3.8 | 51 | 96.2 | 1 |
Pulmonary nodule | 1 | 1.9 | 52 | 98.1 | – | – | – | – | – |
Atelectasis | 13 | 24.5 | 40 | 75.5 | 11 | 20.8 | 42 | 79.2 | 0.68 |
Ground glass opacity (GGO) | 51 | 96.2 | 2 | 3.8 | 51 | 96.2 | 2 | 3.8 | 1 |
Linear opacity | – | – | – | – | – | – | – | – | – |
Reserve halo sign | – | – | – | – | – | – | – | – | – |
Emphysema | – | – | – | – | – | – | – | – | – |
Peribronchial thickening | – | – | – | – | – | – | – | – | – |
Pleural effusion | – | – | – | – | – | – | – | – | – |
Mosaic attenuation | – | – | – | – | – | – | – | – | – |
LAPCT | – | – | – | – | – | – | – | – | – |
Crazy paving | – | – | – | – | – | – | – | – | – |